弥漫性泛细支气管炎病例分析  

The Clinical Analysis of 23 Cases of Diffuse Panbronchiolitis

作　　者：郝珍[1] 冯长顺[1] 

机构地区：[1]解放军总医院,北京市100853

出　　处：《中国病案》2016年第6期91-92,共2页Chinese Medical Record

摘　　要：目的提高对弥漫性泛细支气管炎(DPB)重视,减少临床误诊。方法对2012年3月-2014年3月在某院门诊诊治的23例影像学达到3期以上改变的DPB患者做了详细临床分析,并对治疗效果进行了随访观察。结果 23例患者均有多次就诊经历,平均病程13个月(1年-2年),均曾被诊断为支气管扩张;修正诊断后,给予罗红霉素150mg,每日2次,病情有不同程度的改善,治疗2个月时,78.26%患者达到显著效果,21.74%患者有效。结论弥漫性泛细支气管炎且并非少见病,是门诊最容易误诊的肺部疾病之一,对DPB的认识与重视均有待于进一步加强;大环内酯类药物是治疗弥漫性泛细支气管炎主要有效药物,尽早给予治疗对患者的预后至关重要。Objective To improve the understanding and pay much attention to diffuse panbronchiolitis（DPB）,reduce misdiagnosis. Methods From March 2012 to March 2014, 23 patients with DPB, which lung imaging lesion are more than 3 period, was made a careful clinical analysis, and follow-up observation. Results Once many times to see the doctor in all the 23 cases, the average sicken time 13 months（1 ~ 2 years）, and were misdiagnosed as bronchiectasis. Correct diagnosis, the 23 cases of DPB patients were treated with luo erythromycin, of which 18 patients had significant effect,and 5 case of effective.Conclusion DPB is one of lung disease the most easily misdiagnosed diseases.The DPB to understanding and pay attention to still need further improve; Macrolides are the main effective drugs for DPB,give treatment as soon as possible is very important for the prognosis of patient with DPB.

关 键 词：弥漫性泛细支气管炎 支气管扩张 分析 

分 类 号：R562.21[医药卫生—呼吸系统]